Human BBB-on-a-chip reveals barrier disruption, endothelial inflammation, and T cell migration under neuroinflammatory conditions.

Front Mol Neurosci · 2023 · PMC10561300 · PMID 37818458

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Natalizumab treatment significantly reduced T cell adhesion to inflamed BBBs-on-chips and showed a trend towards reduced migration.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.